Identity, Access Management and Cybersecurity Solutions Provider BIO-key International Hosts Q1 Investor Call Tues., June 18th at 10am ET
BIO-key International (NASDAQ: BKYI), a leader in Identity and Access Management (IAM) and Identity-Bound Biometric solutions, has announced it will hold its Q1 2024 investor call on Tuesday, June 18th at 10 a.m. ET. The company's Chairman & CEO Mike DePasquale and CFO Cecilia Welch will lead the conference and Q&A session. BIO-key's recent financial highlights include a stock price of $1.76, 2023 revenue of $7.8M, a 10.5% revenue growth, and a market cap of $3.3M. The conference call will provide a platform for discussing Q1 2024 results, which will be released prior to the call. The call can be accessed via dial-in numbers for U.S. and international participants, with a webcast and replay available for three months.
- Recent price of $1.76 shows market valuation.
- 2023 revenue stood at $7.8M.
- Revenue growth of 10.5% in 2023.
- Market cap of $3.3M.
- No specific Q1 financial data provided yet.
- Potential dilution with 1.9M common stock and equivalents outstanding.
- Low Price/2023 Sales ratio of 0.4X.
HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m. ET. Results will be released prior to the call. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference and Q&A session.
| Conference Call Details | ||||||
| Date / Time: | Tuesday, June 18th at 10 a.m. ET | |||||
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 Int’l | |||||
| Live Webcast / Replay: | Webcast & Replay Link – Available for 3 months. | |||||
| Audio Replay: | 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 1988012 | |||||
| BIO-key at a Glance | ||||||
| Recent Price | 2023 Revenue | |||||
| Shares Out.* | 1.9M | 2023 Revenue Growth | + | |||
| Market Cap | Price/2023 Sales | 0.4X | ||||
* Common stock and common stock equivalents outstanding.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 40 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key | ||
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ | |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international | |
| Twitter – Corporate: | @BIOkeyIntl | |
| Twitter – Investors: | @BIO_keyIR | |
| StockTwits: | BIO_keyIR | |
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
FAQ
When is BIO-key International's Q1 2024 investor call?
What is the stock symbol for BIO-key International?
How can I access the BIO-key International investor call?
What were BIO-key International's 2023 revenue figures?
What is the revenue growth for BIO-key International in 2023?
How many shares does BIO-key International have outstanding?
What is BIO-key International's market cap as of the latest update?
What is BIO-key International's Price/2023 Sales ratio?
